Trials / Completed
CompletedNCT04551599
A Study of the Effects of Food and Age on Danicopan
A Two-Part, Open-Label Phase 1 Study to Evaluate the Effect of Food and Age on the Pharmacokinetics of Danicopan
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Alexion Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This will be an open-label, 2-part study. Part 1 will be a randomized, 2-sequence, 2-period crossover, food-effect study in healthy young adult participants. Part 2 will be a 1-period age-effect study in healthy elderly male participants.
Detailed description
This will be an open-label, 2-part study. Part 1 will be a randomized, 2-sequence, 2-period crossover, food-effect study in healthy young adult participants. Part 2 will be a 1-period age-effect study in healthy elderly male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Danicopan | A single dose of danicopan (200 milligrams) will be administered orally. |
Timeline
- Start date
- 2020-02-21
- Primary completion
- 2021-02-03
- Completion
- 2021-02-03
- First posted
- 2020-09-16
- Last updated
- 2023-01-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04551599. Inclusion in this directory is not an endorsement.